Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
2.
Proc Natl Acad Sci U S A ; 109(8): 2995-3000, 2012 Feb 21.
Article in English | MEDLINE | ID: mdl-22323595

ABSTRACT

Nucleotide excision repair (NER) defects are associated with cancer, developmental disorders and neurodegeneration. However, with the exception of cancer, the links between defects in NER and developmental abnormalities are not well understood. Here, we show that the ERCC1-XPF NER endonuclease assembles on active promoters in vivo and facilitates chromatin modifications for transcription during mammalian development. We find that Ercc1(-/-) mice demonstrate striking physiological, metabolic and gene expression parallels with Taf10(-/-) animals carrying a liver-specific transcription factor II D (TFIID) defect in transcription initiation. Promoter occupancy studies combined with expression profiling in the liver and in vitro differentiation cell assays reveal that ERCC1-XPF interacts with TFIID and assembles with POL II and the basal transcription machinery on promoters in vivo. Whereas ERCC1-XPF is required for the initial activation of genes associated with growth, it is dispensable for ongoing transcription. Recruitment of ERCC1-XPF on promoters is accompanied by promoter-proximal DNA demethylation and histone marks associated with active hepatic transcription. Collectively, the data unveil a role of ERCC1/XPF endonuclease in transcription initiation establishing its causal contribution to NER developmental disorders.


Subject(s)
DNA Repair/genetics , Growth and Development/genetics , Progeria/genetics , Transcription, Genetic , Adipogenesis/genetics , Animals , Animals, Newborn , DNA Methylation/genetics , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/metabolism , Disease Models, Animal , Endonucleases/deficiency , Gene Expression Regulation, Developmental , Genome/genetics , Histones/metabolism , Liver/growth & development , Liver/metabolism , Liver/pathology , Mice , Organ Specificity , Progeria/enzymology , Progeria/pathology , Promoter Regions, Genetic/genetics , Protein Binding/genetics , Protein Processing, Post-Translational/genetics , Transcription Factor TFIID/metabolism , Transcriptome/genetics
3.
J Immunol ; 187(7): 3712-20, 2011 Oct 01.
Article in English | MEDLINE | ID: mdl-21880987

ABSTRACT

The human CD2 (hCD2) locus control region (LCR) inserted in the mouse CD8 gene complex activates expression of the CD8 genes in T cell subsets in which the CD8 locus is normally silenced (e.g., CD4(+) single-positive T cells). In this article, we show that, in conditional mCD8/hCD2-LCR (CD8/LCR) knock-in mice, the continuous presence of the hCD2-LCR is required for this effect. Deletion of the inserted hCD2-LCR in a developmental stage and cell lineage-specific manner revealed that the temporary presence of the LCR during early development does not permanently alter the expression pattern of the CD8 genes. As a result, cells that have been affected by the insertion of the LCR can convert to their destined phenotype once the LCR is removed. DNaseI hypersensitive sites 1 and 2 of the hCD2-LCR influence the expression of the CD8 genes in a similar manner as does the full LCR, whereas insertion of hypersensitive site 3 alone of the LCR does not result in a changed expression pattern. This analysis revealed a dynamic interaction between the hCD2-LCR and the endogenous regulatory elements of the CD8 genes.


Subject(s)
CD2 Antigens/genetics , CD8 Antigens/genetics , Gene Expression Regulation/immunology , Locus Control Region/genetics , Lymphopoiesis/genetics , T-Lymphocytes/cytology , Animals , Blotting, Southern , CD2 Antigens/immunology , CD8 Antigens/immunology , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Lineage/genetics , Cell Lineage/immunology , Cell Separation , Flow Cytometry , Gene Expression , Gene Knock-In Techniques , Humans , Locus Control Region/immunology , Mice , T-Lymphocytes/immunology
4.
Mol Med ; 15(11-12): 415-24, 2009.
Article in English | MEDLINE | ID: mdl-19690621

ABSTRACT

Natural deletions of the human gamma-globin gene cluster lead to specific syndromes characterized by increased production of fetal hemoglobin in adult life and provide a useful model to delineate novel cis-acting elements involved in the developmental control of hemoglobin switching. A hypothesis accounting for these phenotypic features assumes that silencers located within the Agamma-to delta-gene region are deleted in hereditary persistence of fetal hemoglobin (HPFH) and deltabeta-thalassemias, leading to failure of switching. In the present study, we sought to clarify the in vivo role of two elements, termed Enh and F, located 3' to the Agamma-globin, in silencing the fetal genes. To this end, we generated three transgenic lines using cosmid constructs containing the full length of the globin locus control region (LCR) linked to the 3.3-kb Agamma-gene lacking both the Enh and F elements. The Enh/F deletion resulted in high levels of Agamma-globin gene expression in adult mice in all single copy lines, whereas, the LCR-Agamma single copy lines which retain the Enh and F elements exhibited complete normal switching of the fetal Agamma-gene. Our study documents directly for the first time the in vivo role of these two gene-proximal negative regulatory elements in silencing the fetal globin gene in the perinatal period, and thus these data may permit their eventual exploitation in therapeutic approaches for thalassemias.


Subject(s)
Fetal Proteins/genetics , Gene Deletion , Silencer Elements, Transcriptional , gamma-Globins/genetics , Animals , Fetal Proteins/biosynthesis , Fetal Proteins/metabolism , Humans , In Situ Hybridization, Fluorescence , Mice , Mice, Transgenic , Polymerase Chain Reaction , gamma-Globins/metabolism
5.
Cell Metab ; 18(3): 403-15, 2013 Sep 03.
Article in English | MEDLINE | ID: mdl-24011075

ABSTRACT

Lipodystrophies represent a group of heterogeneous disorders characterized by loss of fat tissue. However, the underlying mechanisms remain poorly understood. Using mice carrying an ERCC1-XPF DNA repair defect systematically or in adipocytes, we show that DNA damage signaling triggers a chronic autoinflammatory response leading to fat depletion. Ercc1-/- and aP2-Ercc1F/- fat depots show extensive gene expression similarities to lipodystrophic Pparγ(ldi/+) animals, focal areas of ruptured basement membrane, the reappearance of primary cilia, necrosis, fibrosis, and a marked decrease in adiposity. We find that persistent DNA damage in aP2-Ercc1F/- fat depots and in adipocytes ex vivo triggers the induction of proinflammatory factors by promoting transcriptionally active histone marks and the dissociation of nuclear receptor corepressor complexes from promoters; the response is cell autonomous and requires ataxia telangiectasia mutated (ATM). Thus, persistent DNA damage-driven autoinflammation plays a causative role in adipose tissue degeneration, with important ramifications for progressive lipodystrophies and natural aging.


Subject(s)
Adipose Tissue/metabolism , DNA Damage , Adipocytes/cytology , Adipocytes/metabolism , Animals , Ataxia Telangiectasia Mutated Proteins/metabolism , Cells, Cultured , Cytokines/metabolism , DNA Repair , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Endonucleases/deficiency , Endonucleases/genetics , Endonucleases/metabolism , Fanconi Anemia Complementation Group Proteins/metabolism , Fatty Acid-Binding Proteins/genetics , Fatty Acid-Binding Proteins/metabolism , Histones/metabolism , Mice , Mice, Knockout , PPAR gamma/genetics , PPAR gamma/metabolism , Progeria/metabolism , Progeria/pathology , Rad51 Recombinase/metabolism , Transcriptome
7.
Blood ; 101(7): 2591-600, 2003 Apr 01.
Article in English | MEDLINE | ID: mdl-12517813

ABSTRACT

To probe the pathophysiologic mechanisms underlying neutropenia in patients with chronic idiopathic neutropenia (CIN) with hypoplastic and left-shifted granulocytic series in the bone marrow (BM), we have studied granulocytopoiesis in 32 adults with CIN by evaluating the number and survival characteristics of cells in several stages of granulocyte differentiation using flow cytometry and BM culture assays. We found that patients with CIN displayed a low percentage of CD34(+)/CD33(+) cells, defective granulocyte colony-forming unit (CFU-G) growth potential of BM mononuclear or purified CD34(+) cells, and low CFU-G recovery in long-term BM cultures (LTBMCs), compared with controls (n = 46). A low percentage of CD34(+)/CD33(+) cells in patients was associated with accelerated apoptosis and Fas overexpression within this cell compartment compared with controls. No significant difference was documented in the percentage of apoptotic cells or the Fas(+) cells within the fractionated CD34(+)/CD33(-), CD34(-)/CD33(+), and CD34(-)/CD33(-)/CD15(+) BM subpopulations or the peripheral blood neutrophils, suggesting that the underlying cellular defect in CIN probably concerns the committed granulocyte progenitors. LTBMC stromal layers from patients produced abnormally high amounts of tumor necrosis factor alpha and cytokine levels in culture supernatants inversely correlated with the number of myeloid progenitor cells and positively with the proportion of apoptotic CD34(+) cells. Patient LTBMC stromal layers displayed pathologic interferon gamma and Fas-ligand mRNA expression and failed to support normal myelopoiesis. These data suggest that impaired granulocytopoiesis in CIN is probably due to overproduction of inflammatory cytokines by immune cells within the BM microenvironment that may exert an inhibitory effect on myelopoiesis by inducing Fas-mediated apoptosis in the granulocyte progenitors.


Subject(s)
Apoptosis , Granulocytes/pathology , Myeloid Progenitor Cells/pathology , Myelopoiesis , Neutropenia/pathology , Adult , Aged , Bone Marrow Cells/pathology , Case-Control Studies , Cell Culture Techniques , Cell Differentiation , Chronic Disease , Cytokines/biosynthesis , Cytokines/metabolism , Female , Humans , Immunity, Cellular , Male , Middle Aged , Neutropenia/etiology , Stromal Cells/cytology
SELECTION OF CITATIONS
SEARCH DETAIL